CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2020	Mar. 31, 2019
CURRENT ASSETS
Cash	$ 9,604,780	$ 3,828,074
Accounts receivable	206,729	0
Prepaid expenses and other current assets	229,604	210,042
TOTAL CURRENT ASSETS	10,041,113	4,038,116
Property and equipment, net	140,484	6,021
Right-of-use lease asset	136,426	0
Patents, net	57,504	66,668
Deposits	12,159	12,159
TOTAL ASSETS	10,387,686	4,122,964
CURRENT LIABILITIES
Accounts payable	285,036	131,931
Due to related parties	111,707	83,654
Convertible notes payable, net	0	962,301
Deferred revenue	100,000	0
Lease liability, current portion	98,557	0
Other current liabilities	472,420	646,000
TOTAL CURRENT LIABILITIES	1,067,720	1,823,886
Lease liability, less current portion	42,540	0
TOTAL LIABILITIES	1,110,260	1,823,886
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2020 and 2019; 9,367,171 and 1,266,979 issued and outstanding at March 31, 2020 and 2019, respectively	9,368	1,267
Additional paid-in capital	121,426,563	108,076,275
Accumulated deficit	(112,026,381)	(105,652,433)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS	9,409,550	2,425,109
NONCONTROLLING INTERESTS	(132,124)	(126,031)
TOTAL STOCKHOLDERS' EQUITY	9,277,426	2,299,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 10,387,686	$ 4,122,964